News
-
-
-
PRESS RELEASE
THERANEXUS PUBLISHES ITS CASH POSITION AS OF 31 DECEMBER 2024 AND PRESENTS ITS PROGRESS REPORT
Theranexus announces cash position of €4.0 M as of 29 January 2025, strengthening financial outlook. Biopharmaceutical company progressing on rare neurological disease treatments, including Niemann-Pick and Gaucher diseases -
-
PRESS RELEASE
Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase
Affluent Medical completes pilot phase of Artus urinary sphincter clinical study with 10 successful human implantations, reporting promising results and safety profile -
-
PRESS RELEASE
Affluent Medical announces 10th successful human implantation of its Artus urinary sphincter, marking completion of the pilot phase.
Affluent Medical completes pilot phase with 10th successful human implantation of Artus urinary sphincter, showing promising results for stress urinary incontinence treatment -
-
-